The discovery of tarloxotinib bromide*: A first-in-class hypoxia-activated tyrosine kinase inhibitor
Login
University Home
→
Library
JavaScript is disabled for your browser. Some features of this site may not work without it.
The discovery of tarloxotinib bromide*: A first-in-class hypoxia-activated tyrosine kinase inhibitor
Smaill, J
;
Lu, Guo-Liang
;
Lee, Ho
;
Abbattista, Maria
;
Guise, Christopher
;
Hsu, Huai-Ling
;
Jaiswal, Jagdish
;
Jamieson, Stephen
;
Ashoorzadeh, Amir
;
Anderson, Robert
;
Patterson, Adam
Identifier:
http://hdl.handle.net/2292/27745
Issue Date:
2015
Reference:
2015
Rights (URI):
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
Show full item record
Files in this item
Name:
smaillwithcoversh ...
Size:
51.07Kb
Format:
PDF
Description:
Accepted version
Related URL:
http://www.nzsoncology.org.nz/files/docs/2015%20conference/monday%20abstracts.pdf
This item appears in the following Collection(s)
Conference Items
[4368]
Share
Search ResearchSpace
Search ResearchSpace
This Collection
Browse
All of ResearchSpace
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Statistics
View Usage Statistics